To investigate the effect of thyroxin on the gene expression of uncoupling protein2(UCP2) in white adipose tissue(WAT) of the rat.Methods:30 normal male Wistar rats were randomly divided into three groups: control group, hyperthyroid group and hypothyroid group, with 10 rats per group. The hyperthyroid or hypothyroid status of the rats was made by administration of Lthyroxine or methimazole. The serum total T3, T4 concentrations were measured by radioimmunoassay(RIA). The mRNA levels in UCP2 in WAT were detected by semiquantitative reverse transcription polymerase chain reaction(RTPCR). Results:Compared with the normal control group, a 1.4 fold increase and a 1.2 fold decrease in UCP2 mRNA were detected in hyperthyroid and hypothyroid groups respectively. The differences were both highly significant.Conclusion:Gene expression of UCP2 in rat WAT was upregulated by thyroxin.
To study the methods for extraction of lentinan and amino acids from the foot body of lentinus edodes. Methods:Lentinan and amino acids were extracted from the foot body and cap of lentinus edodes with cellulase and warm water separately. The contents of these active principles were determined by spectrophotometry.Results:The contents of lentinan in extracts of the foot body and cap of the mushroom that had been subjected to enzymatic hydrolysis were increased by 54% and 44%, respectively, as compared with those in extracts of the plant without enzymatic hydrolysis. However, with the same enzymatic hydrolysis method, the contents of amino acids in extracts of the food body and cap of lentinus edodes were increased only by 10% and 15%, respectively. Conclusion:It seems advisable to use the cellulase hydrolysis method for the extraction of lentinan and warm water hydrolysis method for that of amino acids from the foot body of lentinus edodes, respectively.
Objective:To study the therapeutic effectiveness and safety rate of essential phospholipids (EPL) in the treatment of alcoholic hepatopathy. Methods:45 patients with alcoholic hepatopathy were given each 500 mg of EPL injection in 250 mL of 5% or 10% glucose solution administered by slow IV instillation q.d., supplemented with routine supportive measures. The course of treatment lasted 8 weeks. All patients were subjected to routine physical examination, assay of liver function and liver fibrosis indices including hyaluronic acid and PⅢP before and after the termination of treatment. Results:At the termination of the treatment, the rate of excellent clinical response was 57.8%(26/45), that of moderate improvement 28.9%(13/45) and only 6 patients (13.3%) were unaffected. Conclusion:EPL was shown to be a safe and effective drug in the treatment of alcoholic hepatopathy.